Semaglutide-Mediated Lithium Toxicity
- PMID: 40440507
- DOI: 10.1097/JCP.0000000000002017
Semaglutide-Mediated Lithium Toxicity
References
-
- Maselli DB, Camilleri M. Effects of GLP-1 and its analogs on gastric physiology in diabetes mellitus and obesity. Adv Exp Med Biol. 2020;1307:171–192.
-
- Bækdal TA, Borregaard J, Hansen CW, et al. Effect of oral semaglutide on the pharmacokinetics of lisinopril, warfarin, digoxin, and metformin in healthy subjects. Clin Pharmacokinet. 2019;58:1193–1203.
-
- Calvarysky B, Dotan I, Shepshelovich D, et al. Drug-drug interactions between glucagon-like peptide 1 receptor agonists and oral medications: a systematic review. Drug Saf. 2024;47:439–451.
-
- Acosta A, Camilleri M, Burton D, et al. Exenatide in obesity with accelerated gastric emptying: a randomized, pharmacodynamics study. Physiol Rep. 2015;3:e12610.
-
- Halawi H, Khemani D, Eckert D, et al. Effects of liraglutide on weight, satiation, and gastric functions in obesity: a randomised, placebo-controlled pilot trial. Lancet Gastroenterol Hepatol. 2017;2:890–899.
LinkOut - more resources
Full Text Sources
